Macular Disease Foundation Australia logo

    Macula Matters: August 2021

    The latest email newsletter for HCPs from MDFA.

    Macula Matters

    A macular disease update for eye health professionals

    In this edition, we’re excited to share our new CPD course on diabetic eye disease for optometrists, available now through MDFA’s website. The content has been developed by leading retinal specialists and has received Optometry Australia Institute of Excellence Quality Assurance.

    MDFA also offers a free CPD course for optometrists on age-related macular degeneration, and we are hosting a CPD webinar with A/Prof Alex Hunyor about AMD classification, AREDS studies and management.

    This newsletter also features an update on our meeting with Health Minister Greg Hunt about Medicare rebate changes for eye injections, another case study from the Centre For Eye Health, plus free fact sheets and peer support groups that might benefit your patients.

    In this edition…

    • New CPD for optometrists: MDFA launches diabetic eye disease course

      Developed in conjunction with Australia’s leading retinal specialists and reflecting the latest standards of care, this accredited course is made up of two 30-minute eLearning modules and two 15-minute assessments and takes 1.5 hours with assessments.

      MDFA’s new CPD underlines how prevention, early detection and treatment can reduce the incidence and impact of diabetic eye disease – the leading cause of preventable blindness among working-age Australians.


      Take the CPD course

    • MBS eye injection update: MDFA meets Health Minister Greg Hunt

      As part of Macular Disease Foundation Australia’s ongoing campaign against a proposal to cut Medicare rebates for IVI treatment, MDFA CEO Dee Hopkins and Medical Committee Chair A/Prof Alex Hunyor met Minister Greg Hunt at Parliament House in June.


      Hear more about the meeting

    • CPD webinar: AMD: Classification, AREDS studies and Management by A/Prof Alex Hunyor

      This free webinar, chaired by retinal specialist A/Prof Alex Hunyor, will examine the classification of age-related macular degeneration, results and relevance of the AREDS studies, and current referral guidelines and their implications for clinical practice. This webinar is OA-accredited as 1 hour of learning.


      Register for the webinar

    • Seeing the unseen: Why definition matters, a case study brought to you by the Centre For Eye Health

      We look at how soon the patient in this case study needs to be referred to an ophthalmologist.


      Find the answers

    • Patient fact sheet: Macular disease and COVID-19

      This fact sheet provides important and up-to-date information about continuing essential treatment for macular diseases during COVID-19, including eye injections for conditions such as neovascular age-related macular degeneration and diabetic macular oedema.


      Download the fact sheet

    • Patient fact sheet: Macular disease and driving

      Good vision is essential for safe driving, and many people experience changes to their vision as they get older, such as AMD. This fact sheet, developed by VicRoads in collaboration with MDFA, outlines how macular disease patients can continue driving safely for as long as possible.


      View this fact sheet

    • Who is CFEH?

      CFEH brings you the popular case study series in every edition of Macula Matters. But what else does this organisation do?


      Read more about CFEH’s work

    • Peer support for your patients

      Living with macular disease can be isolating for your patients. And MDFA’s peer support might be the answer.


      Discover our peer support services

    Posted: 31 August 2021

    More articles like this